Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) Is Active and Well-Tolerated in Adults with Newly-Diagnosed Acute Lymphoblastic Leuke... von Cassaday, Ryan D., Soma, Lorinda A., Sala-Torra, Olga, Stevenson, Philip A., Percival, Mary-Elizabeth M., Oehler, Vivian G., Shustov, Andrei R., Becker, Pamela S., Halpern, Anna B., Garcia, Kelsey-Leigh, Heye, Christen N., Radich, Jerald P., Estey, Elihu H.

Volltext

Radiographic and High-Throughput Sequencing (HTS)-Based Response Assessment after Brentuximab Vedotin (BV) Plus Ifosfamide, Carboplatin, and Etoposide (ICE) for Relapsed/Refractory... von Cassaday, Ryan D., Fromm, Jonathan R., Cowan, Andrew J., Smith, Stephen D., Libby, Edward N., Philip, Mary, Nartea, Margaret E., Heye, Christen N., Kanan, Sandra L., Behnia, Sanaz, Gopal, Ajay K.

Volltext

Dose-dense Brentuximab Vedotin Plus Ifosfamide, Carboplatin, and Etoposide (DD-BV-ICE) for Second Line Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma: a single center... von Lynch, Ryan C, Cassaday, Ryan D, Smith, Stephen D, Fromm, Jonathan R., Cowan, Andrew J., Warren, Edus H, Shadman, Mazyar S, Shustov, Andrei, Till, Brian G, Ujjani, Chaitra S, Libby, Edward N, Philip, Mary, Coye, Hilary, Heye, Christen N., Kanan, Sandra L., Morris, Karolyn, Rasmussen, Heather, Behnia, Sanaz, Voutsinas, Jenna, Gopal, Ajay K

Volltext